- Advertise
- OLE Scientific Interchange Workshops
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute | Strategic Alliance Partners
Latest from Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC
June 05, 2020
Video
Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.
Dr. Natale on the Evolution of Immunotherapy in NSCLC
May 15, 2020
Video
Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Dr. Natale on the Evolution of Immunotherapy in NSCLC
May 14, 2020
Video
Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer
May 12, 2020
Video
Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.
Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer
May 11, 2020
Video
Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.